May 2022

New Mobile Game Title: Virtual Interactive Technologies Corp. Signs Agreement With Hammer Slammer Games Gmbh

Gamers will definitely find this news from Berlin thrilling, as Virtual Interactive Technologies Corp., (OTC:VRVR) signed an agreement with Hammer Slammer Games Gmbh (“HSG”). Both companies have decided to come to form a partnership and ... [Read]

How to Make Money With Penny Stocks During a Recession

May 31 Boboye Adeyemi

Recession periods are generally not a great time for trading penny stocks. However, some people still find ways to make money during recession periods, because they know the right strategies to use to make money ... [Read]

Is Better Therapeutics Today’s Best Penny Stock Play?

May 27 Ken Dare

Better Therapeutics (NASDAQ:BTTX) is a stock on the move. Over the past month, the microcap stock has posted gains of 80%, according to PennyStocks.com. At last check, the stock had reached $2.28 in early trading ... [Read]

Top 3 Penny Stocks That You May Want to Set Your Sight on After Their Massive Rise in May 2022

May 26 Adewumi Victor

Penny stocks have always been an intriguing aspect of the stock market due to their high risk and high reward nature. Trading penny stocks can be a very profitable venture if one understands its basics and has ... [Read]

Snapchat is Beginning to Drag the Stock Market Down With It

Snapchat (SNAP) is Beginning to Drag the Stock Market Down With It

May 25 Boboye Adeyemi

For investors, the stock market is undoubtedly one filled with mixed emotions. You laugh when the market is bullish and, on the other hand, feel sad and emotional when the market is bearish. Whichever way ... [Read]

CytoSorbents to Present at Two Upcoming Investor Conferences

May 19

PR Newswire MONMOUTH JUNCTION, N.J. , May 19, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces ... [Read]

Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear at the American Society of Gene and Cell Therapy 25th Annual Meeting

May 19

– Nonclinical data demonstrate that a single intracochlear administration of an AAVAnc80 vector led to durable restoration of auditory function and was well tolerated, supporting planned clinical development of AK-OTOF for the treatment of OTOF ... [Read]

Month: May 2022

New Mobile Game Title: Virtual Interactive Technologies Corp. Signs Agreement With Hammer Slammer Games Gmbh

Snapchat (SNAP) is Beginning to Drag the Stock Market Down With It

CytoSorbents to Present at Two Upcoming Investor Conferences

Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear at the American Society of Gene and Cell Therapy 25th Annual Meeting

Atalaya Mining PLC Announces Q1 2022 Financial Results

Magic Software (MGIC) Upgraded to Buy: Here’s What You Should Know